🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Contineum Therapeutics, Inc. (CTNM)
NASDAQ: CTNM · Real-Time Price · USD
8.68
-0.36 (-3.98%)
At close: Nov 20, 2026, 4:00 PM EST
8.80
+0.12 (1.38%)
After-hours: Nov 20, 2026, 7:30 PM EST

Contineum Therapeutics Stock Forecast

Stock Price Forecast

According to 8 analysts polled by S&P Global, Contineum Therapeutics stock has a consensus rating of "Buy" and an average price target of $21.43. The average 1-year stock price forecast is 146.89% higher than the current stock price, while the lowest is $14 (+61.29%) and the highest is $30 (+245.62%).

Price Target: $21.43 (+146.89%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$14$21.43$22$30
Change+61.29%+146.89%+153.46%+245.62%

Analyst Ratings

The average analyst rating for Contineum Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingJun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Strong Buy566655
Buy111111
Hold111122
Sell000000
Strong Sell000000
Total788888

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Morgan Stanley
Morgan Stanley
Hold
Reiterates
$17
HoldReiterates$17+95.85%Nov 18, 2026
RBC Capital
RBC Capital
Buy
Maintains
$21
BuyMaintains$21+141.94%Nov 4, 2026
JonesTrading
JonesTrading
Buy
Reiterates
$30
BuyReiterates$30+245.62%Nov 4, 2026
Robert W. Baird
Robert W. Baird
Hold
Downgrades
$19 → $14
HoldDowngrades$19 → $14+61.29%Oct 14, 2026
Stifel Nicolaus
Stifel Nicolaus
Buy
Reiterates
$29 → $28
BuyReiterates$29 → $28+222.58%Oct 12, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.79
from -2.17
EPS Next Year
-2.10
from -1.79
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026E
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
--50.00M---
Operating Income
-28.65M-22.72M16.08M-50.89M-68.06M-77.34M
EPS
-----2.17-1.79
Free Cash Flow
-----55.54M-60.00M
No. Analysts
-----6
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
Highn/a
Avgn/a
Lown/a

Revenue Growth

Revenue Growth20272028
High-
Avg-
Low-

EPS Forecast

EPS202620272028
High-1.72
Avg-1.79
Low-1.83

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-